Investment News

18h

Sun Pharma $11.75B Organon Buy; China Blocks Manus

  • Two decisive investment moves in 24 hours: Sun Pharma agreed to buy Organon for $11.75 billion, accelerating consolidation in specialty pharmaceuticals and raising debt-integration questions; China ordered Meta to unwind its $2 billion acquisition of AI startup Manus, signaling heightened geopolitical scrutiny over cross-border AI deals. Both actions reshape risk profiles for corporate M&A and investor allocations.
CTA-image

Market Movers (Top 10)
Last Updated:
Market Movers (Bottom 10)
Last Updated: